A detailed history of Kestra Advisory Services, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 57,184 shares of AMRN stock, worth $39,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,184
Previous 44,066 29.77%
Holding current value
$39,456
Previous $38,000 31.58%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.82 - $1.35 $10,756 - $17,709
13,118 Added 29.77%
57,184 $50,000
Q4 2023

Feb 14, 2024

SELL
$0.66 - $0.91 $2,921 - $4,028
-4,427 Reduced 9.13%
44,066 $38,000
Q3 2023

Nov 09, 2023

BUY
$0.85 - $1.43 $510 - $858
600 Added 1.25%
48,493 $44,000
Q2 2023

Aug 11, 2023

SELL
$1.12 - $1.49 $764 - $1,017
-683 Reduced 1.41%
47,893 $56,000
Q1 2023

May 12, 2023

BUY
$1.19 - $2.19 $5,003 - $9,208
4,205 Added 9.48%
48,576 $72,000
Q4 2022

Jan 31, 2023

SELL
$1.07 - $1.34 $4,591 - $5,749
-4,291 Reduced 8.82%
44,371 $53,000
Q3 2022

Nov 01, 2022

BUY
$1.09 - $1.67 $1,157 - $1,773
1,062 Added 2.23%
48,662 $53 Million
Q2 2022

Aug 12, 2022

BUY
$1.13 - $3.69 $4,264 - $13,926
3,774 Added 8.61%
47,600 $71,000
Q1 2022

Apr 26, 2022

SELL
$2.85 - $3.73 $24,692 - $32,316
-8,664 Reduced 16.51%
43,826 $144,000
Q4 2021

Jan 20, 2022

SELL
$3.24 - $5.18 $8,453 - $13,514
-2,609 Reduced 4.74%
52,490 $176,000
Q3 2021

Oct 19, 2021

BUY
$3.94 - $5.84 $1,635 - $2,423
415 Added 0.76%
55,099 $281,000
Q2 2021

Jul 28, 2021

SELL
$4.26 - $6.5 $36,831 - $56,199
-8,646 Reduced 13.65%
54,684 $239,000
Q1 2021

May 10, 2021

SELL
$5.03 - $8.8 $19,667 - $34,408
-3,910 Reduced 5.81%
63,330 $393,000
Q4 2020

Jan 20, 2021

SELL
$4.04 - $5.31 $70,607 - $92,802
-17,477 Reduced 20.63%
67,240 $352 Million
Q3 2020

Nov 12, 2020

BUY
$3.64 - $7.76 $308,369 - $657,403
84,717 New
84,717 $356 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $278M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.